Valencell
With more than 10 patents to his credit, Mike is responsible for R&D and product development initiatives for Valencell. Prior to Valencell, he managed budgets over $3M while transitioning innovative electronics technology from R&D to production at Northrop Grumman Electronic Systems. Mike holds several degrees including a M.S. in Technical Management from Johns Hopkins University and a Ph.D., M.S. and B.S. in Electrical Engineering from North Carolina State University.
Valencell
Valencell transforms the science of wearable biometrics to enable impactful health outcomes. Through innovative R&D and validated technologies, we develop breakthroughs and collaborate with wearables, hearables, and medical device companies around the world to deliver amazing results. With more than 85 granted patents and 100+ patents pending around the world, Valencell’s technology continuously and accurately measures real-time biometric and physiological data that powers meaningful consumer and patient insights. Valencell was founded in 2006 and headquartered in Raleigh, North Carolina. Investors include Halma, Sonion, TDF Ventures, GII TECH, and WSJ Joshua Fund.